Proactive - Interviews for investors

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share some exciting updates. Firstly, Sobel announced the company's upcoming participation as the title sponsor of the 2024 BIO CEO & Investor Conference, scheduled to take place in New York City from February 26-27, 2024. Sobel, along with BioHarvest's Chairman, Zaki Rakib, and Chief Medical Officer, Dr. Brian Cornblatt, will be in attendance. Sobel is also slated to host a presentation during the conference to showcase the company's developments and future plans to attendees.

In addition to the conference participation, Sobel revealed that BioHarvest has enlisted the services of investor relations specialists MZ Group to lead a strategic investor relations and financial communications program across all key markets. MZ will collaborate closely with BioHarvest's management team to develop and execute a comprehensive capital markets strategy aimed at enhancing the company's visibility within the investment community.

The initiative will spotlight BioHarvest's groundbreaking Botanical Synthesis technology platform, which holds the potential to revolutionize the industrial-scale production of active ingredients found in plants for the development of nutraceutical and pharmaceutical health and wellness products. Notably, BioHarvest's flagship grape-derived product, VINIA®, has been driving robust revenue growth, and the company is actively expanding its product lines to capitalize on this momentum.

These developments underscore BioHarvest's commitment to leveraging its innovative technology and commercial successes to position itself as a leader in the health and wellness industry.

#proactivinvestors #cse #bhsc #otcqb #cnvcf #pharma #biotech #hearthealth

#CEOInterview, #BioConference, #NYCEvent, #InvestorRelations, #BotanicalSynthesis, #HealthTech, #Biotech, #Pharmaceuticals, #Cosmeceuticals, #Nutraceuticals, #Innovation, #Technology, #Investment, #BusinessGrowth, #HealthAndWellness, #InvestorEngagement, #ScalingBusiness, #Roadshows, #FutureOfHealth, #MedicalTechnology, #HealthcareIndustry, #InvestorOutreach, #NewYorkCity, #2024GrowthPlans

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Cardiol Therapeutics CEO David Elsley joined Steve Darling from Proactive to share some significant news: the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for the company's lead small molecule drug candidate aimed at treating pericarditis, including recurrent pericarditis. This designation is a major validation of CardiolRx's potential in addressing a debilitating heart condition.

Elsley explained that recurrent pericarditis is a serious heart disease characterized by symptoms that significantly impact patients' quality of life and physical activity. The FDA's decision to grant ODD underscores the potential of CardiolRx to improve the lives of individuals suffering from this condition.

MAvERIC-Pilot is a Phase II open-label pilot study investigating the tolerance, safety, and effect of CardiolRx™ administered to patients with recurrent pericarditis. In addition to standard safety assessments, MAvERIC-Pilot is designed to evaluate improvement in objective measures of this rare disease.

Orphan Drug Designation is granted by the FDA to drugs or biological products intended to prevent, diagnose, or treat rare diseases or conditions affecting fewer than 200,000 people in the United States. This designation offers several benefits to sponsors, including potential seven-year marketing exclusivity, exemptions from certain FDA fees, and tax credits for qualified clinical trials. Additionally, products with ODD may qualify for accelerated regulatory review through Fast Track, Breakthrough Therapy, or Priority Review designations.

This milestone represents a significant advancement for Cardiol Therapeutics and its efforts to develop innovative therapies for cardiovascular diseases. With CardiolRx currently in Phase II clinical trials for recurrent pericarditis and acute myocarditis, the ODD from the FDA further strengthens the company's position in advancing treatments for these conditions

#proactiveinvestors #cardioltherapeuticsinc #nasdaq #crdl #tsx #crdl

#PericarditisTreatment, #OrphanDrugDesignation, #HeartHealth, #MedicalInnovation, #RareDisease, #HealthcareNews, #ClinicalTrials, #FDAApproval, #Biopharmaceutical, #InflammationTreatment, #MedicalResearch, #HealthTech, #PatientCare, #MedicalAdvancements, #HeartDiseaseAwareness, #PublicHealth, #HealthcareIndustry, #Cardiology, #MedicalBreakthroughs, #DrugDevelopment, #HeartMedicine, #HealthcareUpdates, #MedicalScience, #HealthcareTechnology

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Intrusion CEO Tony Scott joined Steve Darling from Proactive to share exciting news about the company's expansion of its key Intrusion Shield SaaS services in the Philippines. This expansion follows the success Intrusion has experienced in the first quarter, with customers in various sectors of the Philippines economy, including natural gas exploration and development, water utilities, and the government sector. The new agreements allow for the broader use of Intrusion Shield protection within these organizations after successful proof of concepts.

Scott emphasized that cyber-attacks have been increasing worldwide, underscoring the critical need for effective cybersecurity solutions. Intrusion believes that its Shield products provide cybersecurity teams with enhanced capabilities to identify, deflect, and eliminate new and emerging cyber threats. The company aims to continue this trend in 2024, leveraging reseller agreements to build a robust sales pipeline and focusing on converting existing proofs of value (POVs) and proof of concepts (POCs) into revenue-generating customers.

Overall, Intrusion is committed to providing advanced cybersecurity solutions to organizations globally, and the expansion of its services in the Philippines reflects its dedication to addressing the evolving cybersecurity challenges faced by businesses and governments around the world.

#proavtiveinvestors #intrusioninc #nasdaq #intz

#Cybersecurity #TonyScott #NetworkSecurity #ZeroDayThreats #InternetTraffic #Firewall #AIinCybersecurity #ITSecurity #DataProtection #CyberThreats #Innovation #GlobalExpansion #Resellers #Technology #InfoSec #DataSecurity #CyberDefense #ITLeadership #TechNews #CyberAttacks #SecuritySolutions #BusinessGrowth #DigitalSecurity #YouTube#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce the company's launch of the next era of GPT AI 3D product solutions. These proprietary Artificial Intelligence algorithms represent a significant advancement in Nextech3D.ai's technology offerings and are poised to drive innovation in the e-commerce industry.

Leading this initiative is Hareesh Achi, a former Microsoft Executive who currently serves as Nextech3D.ai's Head of Product Operations. With Achi's expertise and leadership, the company aims to capitalize on the early stages of the AI opportunity, particularly in the realm of 3D modeling for e-commerce.

Gappelberg emphasized that the transition from 2D to 3D modeling represents a major multi-decade transformation driven by AI. Nextech3D.ai is at the forefront of this transformation, leveraging its suite of GPT AI solutions to provide cutting-edge technology to enterprise clients. The company plans to offer annual enterprise licensing deals for its suite of GPT AI solutions, which initially feature 12 GPTs. Moreover, Nextech3D.ai intends to develop additional GPTs throughout 2024, further expanding its product offerings and market reach.

By focusing on enterprise licensing deals and advancing its suite of AI solutions, Nextech3D.ai is well-positioned to capitalize on the growing demand for innovative 3D technologies in the e-commerce landscape. This initiative underscores the company's commitment to driving technological innovation and delivering value to its clients in the evolving digital marketplace.

#proactiveinvestors #nextech3d.ai #cse #NTAR #otcqb #metaverse #toggle3D

#AI #GPT #3Dmodeling #ArtificialIntelligence #TechNews #Innovation #Microsoft #AR #VR #Technology #Enterprise #Manufacturing #DigitalTransformation #Ecommerce #Gaming #Architecture #AItechnology #FutureTech #Business #Startup #Entrepreneurship #DigitalRevolution #MarketTrends #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

First Phosphate Corp CEO John Passalacqua joined Steve Darling from Proactive to announce a significant development for the company - the signing of a Joint Development Agreement with Integrals Power Limited of Milton Keynes, United Kingdom. This agreement marks a crucial step forward in First Phosphate's efforts to produce battery-grade iron III phosphate precursor for the lithium iron phosphate (LFP) battery industry outside of China.

Passalacqua explained that the agreement outlines an initial phase of joint development focused on creating the technology necessary for producing the iron phosphate precursor for LFP cathode active material (CAM). The goal is to develop a scalable, low-cost, and environmentally compliant process for manufacturing battery-grade iron III phosphate. If successful, this technology could be combined with lithium carbonate or lithium hydroxide to produce LFP CAM.

Furthermore, Passalacqua emphasized the collaborative nature of the agreement, with both parties committed to working together to bring the developed process into immediate large-scale production. Under the agreement, First Phosphate will provide the necessary raw materials for producing iron III phosphate, leveraging its phosphate concentrate and magnetite resources.

This partnership with Integrals Power Limited represents a significant milestone for First Phosphate Corp as it strives to establish itself as a key player in the supply chain for lithium iron phosphate batteries. By developing innovative technologies and forging strategic partnerships, the company is well-positioned to capitalize on the growing demand for sustainable energy storage solutions.

#proactiveinvestors #firstphosphatecorp #phosphate #BéginLamarcheproject

#IntegralsPower, #LFPbattery, #batteryproduction, #sustainableenergy, #cleanenergy, #innovation, #environment, #collaboration, #technology, #partnership, #industrynews, #renewableenergy, #greenfuture, #energysector, #businessdevelopment, #investing, #industryinsights, #cleantech, #sustainability, #manufacturing, #jointdevelopment, #ironphosphate, #NorthAmerica, #Europe#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

U.S. Gold Corp Director Robert Schafer joined Steve Darling from Proactive to discuss the CK gold project in Wyoming, highlighting its strategic advantages. With over 40 years of experience in the mining industry, Schafer emphasized several key points about the project.

Firstly, he highlighted the project's advantageous infrastructure, located near major highways and railroads, which facilitates easy transportation of materials to smelters. This infrastructure advantage enhances the project's economic viability.

Schafer also pointed out the high-quality copper concentrate with significant gold content, making the project economically favorable. Additionally, the low sulphide content in the ore minimizes environmental impact, offering potential benefits such as water storage and road construction.

Furthermore, Schafer underscored the positive relationship between the project and the Wyoming government, highlighting the streamlined permitting process and the project's contribution to the state's Education Fund through royalties.

One of the project's notable strengths is its dual exposure to copper and gold markets, which positions it favorably amidst economic fluctuations. Schafer expressed optimism about the project's promising future, reflecting on its numerous strengths and benefits.

Overall, U.S. Gold Corp is committed to driving forward with the compelling venture in Wyoming's resource-rich landscape, leveraging the project's strategic advantages for long-term success.

#proactiveinvestors #usgoldcorp #nasdaq #usau #mining #gold #copper

#miningindustry, #CKgoldproject, #Wyomingmining, #coppermining, #goldmining, #infrastructure, #environment, #economicdevelopment, #mineralresources, #miningnews, #geology, #miningexperts, #miningeconomics, #miningpermits, #sustainablemining, #miningtechnology, #mininginvestment, #miningcommunity, #resourceexploration, #miningoperations, #metallurgy, #miningregulations, #miningupdates, #miningexpertise

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to share exciting news about the company's success. Ocean Power Technologies has received multiple orders for fully integrated WAM-V Unmanned Surface Vehicles , totaling over $1.25 million. This significant achievement underscores the growing demand for OPT's advanced marine technologies and their applications in various fields such as maritime surveillance, environmental monitoring, and ocean data collection.

The WAM-V USV represents the cutting edge of maritime innovation, offering superior performance in diverse ocean conditions. Its versatility and reliability make it an ideal choice for a wide range of marine applications, from data collection to security surveillance and environmental monitoring.

Stratmann highlighted that the recent commercial orders have come from clients in Latin America, demonstrating the broad capabilities and applications of the WAM-V USVs. OPT's commitment to delivering customizable and scalable solutions has positioned the company as a preferred partner in the industry.

Overall, this success reflects Ocean Power Technologies' dedication to providing innovative solutions that meet the evolving needs of the marine industry, and it marks an exciting milestone in the company's journey towards continued growth and impact in the field of marine technology.

#proactiveinvestors #oceanpowertechnologiesinc #nyseamerican #optt

#AutonomousTechnology, #OceanDataCollection, #RenewableEnergy, #MaritimeSolutions, #EnvironmentalSustainability, #CarbonFootprint, #LatinAmerica, #ATandT5G, #NavalPostgraduateSchool, #ShippingLanes, #NationalSecurity, #BorderControl, #FisheriesMonitoring, #OceanProtection, #GlobalDeployment, #Innovation, #TechnologyNews, #GreenTech, #CleanEnergy, #OceanTech, #MarineScience, #DataAnalytics, #EmergingTech

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

OptionsDesk's Sebastian Blanco joins Proactive's Stephen Gunnion with a focus on economic data, including latest UK and US inflation readings and their impact on financial markets.

The UK inflation rate came in lower than expected, boosting the FTSE 100 index by 1%. Conversely, the US faced a slight setback with inflation rates slightly higher than forecast, affecting expectations for rate cuts and altering the financial narrative.

Blanco also highlighted Uber's robust earnings beat and its announcement of a $7 billion share buyback, showcasing strong investor confidence and a strategic move to enhance shareholder value after reporting its first-ever profits.

On the other hand, Lyft encountered a significant blunder with a typo in its earnings report, mistakenly projecting a 5% growth instead of the accurate 0.5%, which briefly surged its stock price before a correction caused a sharp decline.

‌

#SebastianBlanco #OptionsDesk #EconomicData #USInflation #UKInflation #FTSE100 #FinancialMarkets #Uber #ShareBuyback #LyftEarnings #InvestorConfidence #FinancialAnalysis #MarketTrends #CorporateStrategy #EarningsReport #RateCuts #InvestmentTips

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Poolbeg Pharma chairman Cathal Friel joined Proactive's Stephen Gunnion to discuss his new hands-on role at the company.

Stepping up as the executive chairman at Poolbeg Pharma, Friel expressed his intention to replicate the success he achieved with hVIVO, another company he founded. With the addition of key former Amryt leadership team members to Poolbeg, Friel said he is optimistic about the company's aggressive growth prospects and is focused on share price appreciation.

The chairman also explained the rational for the sale of shares in hVIVO PLC by directors, including himself.

Friel, who has a rich background in mergers and acquisitions (M&A) and investment banking, said the decision was driven by strong institutional demand for hVIVO stock. Despite selling a small portion of his stake, he affirmed his long-term commitment to the company, highlighting its robust growth, profitability, and cash generation under current management.

He also revealed plans to increase his stake in Poolbeg, indicating confidence in the company's potential and his commitment to driving shareholder value.

#PoolbegPharma #CathalFriel #PharmaInvesting #Biotech #MergersAndAcquisitions #InvestmentBanking #HealthcareInnovation #StockMarket #Pharmaceuticals #ExecutiveLeadership #GrowthStrategy #ShareholderValue #BiotechStocks #InvestmentOpportunities #PharmaNews #UKBiotech #StrategicGrowth #InvestorRelations #CorporateStrategy #HealthcareStocks #proactiveinvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

The FTSE 100 shook off the news on Thursday morning that the UK had dipped into a technical recession late last year to open higher.

GDP contracted 0.3% over the final quarter of 2023, according to the ONS, following a 0.1% decline in the previous three months, meaning the UK fell into its first non-COVID-related recession since 2009.

Among companies, British Gas owner Centrica climbed after posting higher-than-expected full-year profit and lifting its dividend.

Airline Jet2 also gained altitude after bumping up its full-year profit expectations on resilient travel sector demand.

And finally, NatWest is reportedly set to discuss interim boss Paul Thwaite’s permanent appointment as chief executive on Thursday, following the departure of former chief executive Alison Rose over the Nigel Farage debanking scandal.

#proactiveinvestors #marketreport #ONS #recession #Centrica #BritishGas #Jet2 #Natwest #NIgelFarage #PaulThwaite #AlisonRose #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews